GlassScriptPhysician profile
Xiaonan Sun
NPI 1295121259
$21,487.81
in general payments reported to CMS, 2019-2025
8 companies · $16K in 2025
The $16K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,818 · 2023: $2,309 · 2024: $1,115 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $6,235 · Food and Beverage: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,158.00 |
| Travel and Lodging | $6,234.99 |
| Food and Beverage | $1,276.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,267.53 | 2022-2025 | Stealthstation S8 Platform, Percept PC Brainsense, Sensight |
| Globus Medical, INC. | $4,404.87 | 2023-2025 | Excelsius Gps, Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System |
| Neuropace, INC. | $744.65 | 2022 | |
| Boston Scientific Corporation | $732.70 | 2024 | Vercise |
| Sanara Medtech INC. | $125.00 | 2022 | |
| Penumbra, INC. | $121.20 | 2022 | |
| Clearpoint Neuro, INC. | $61.36 | 2024 | Clearpoint |
| Abbott Laboratories | $30.50 | 2024 | Infinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaonan Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.